Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2012 1
2014 2
2015 2
2016 2
2017 8
2018 10
2019 8
2020 9
2021 5
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS, Grasel RS, Campacci N, de Paula AE, Galvão HCR, Torrezan GT, Sabato CS, Fernandes GC, Souza CP, Michelli RD, Andrade CE, Barros BDF, Matsushita MM, Revil T, Ragoussis J, Couch FJ, Hart SN, Reis RM, Melendez ME, Tonin PN, Carraro DM, Palmero EI. Felicio PS, et al. Among authors: melendez me. Hum Mutat. 2021 Mar;42(3):290-299. doi: 10.1002/humu.24158. Epub 2020 Dec 28. Hum Mutat. 2021. PMID: 33326660 Free PMC article.
RAD50 Deficient in a Breast Cancer Model Predicts Sensitivity to PARP Inhibitors.
Ramos CRN, Oliveira RJS, Rosa MN, Pereira AS, de Abreu RBV, van Helvoort Lengert A, Reis RM, Silva VAO, Palmero EI, Melendez ME. Ramos CRN, et al. Among authors: melendez me. Curr Cancer Drug Targets. 2023;23(11):900-909. doi: 10.2174/1568009623666230418101511. Curr Cancer Drug Targets. 2023. PMID: 37076963
Serum, plasma and saliva biomarkers for head and neck cancer.
Arantes LMRB, De Carvalho AC, Melendez ME, Lopes Carvalho A. Arantes LMRB, et al. Among authors: melendez me. Expert Rev Mol Diagn. 2018 Jan;18(1):85-112. doi: 10.1080/14737159.2017.1404906. Epub 2017 Nov 20. Expert Rev Mol Diagn. 2018. PMID: 29134827 Review.
Methylation as a biomarker for head and neck cancer.
Arantes LM, de Carvalho AC, Melendez ME, Carvalho AL, Goloni-Bertollo EM. Arantes LM, et al. Among authors: melendez me. Oral Oncol. 2014 Jun;50(6):587-92. doi: 10.1016/j.oraloncology.2014.02.015. Epub 2014 Mar 20. Oral Oncol. 2014. PMID: 24656975 Review.
New insights on familial colorectal cancer type X syndrome.
Garcia FAO, de Andrade ES, de Campos Reis Galvão H, da Silva Sábato C, Campacci N, de Paula AE, Evangelista AF, Santana IVV, Melendez ME, Reis RM, Palmero EI. Garcia FAO, et al. Among authors: melendez me. Sci Rep. 2022 Feb 18;12(1):2846. doi: 10.1038/s41598-022-06782-8. Sci Rep. 2022. PMID: 35181726 Free PMC article.
Colorimetric Detection of SARS-CoV-2 Using Plasmonic Biosensors and Smartphones.
Materón EM, Gómez FR, Almeida MB, Shimizu FM, Wong A, Teodoro KBR, Silva FSR, Lima MJA, Angelim MKSC, Melendez ME, Porras N, Vieira PM, Correa DS, Carrilho E, Oliveira ON Jr, Azevedo RB, Goncalves D. Materón EM, et al. Among authors: melendez me. ACS Appl Mater Interfaces. 2022 Dec 14;14(49):54527-54538. doi: 10.1021/acsami.2c15407. Epub 2022 Dec 1. ACS Appl Mater Interfaces. 2022. PMID: 36454041
The Barretos Cancer Hospital Animal Facility: Implementation and Results of a Dedicated Platform for Preclinical Oncology Models.
Teixeira SA, Luzzi MC, Martin ACBM, Duarte TT, Leal MO, Teixeira GR, Reis MT, Junior CRA, Santos K, Melendez ME, Silva DDCSAD, Bernécule PN, Firmino HVL, Alves ALV, Guimarães DP, Borduqui JV, Laus AC, Mançano BM, Reis RM. Teixeira SA, et al. Among authors: melendez me. Vet Sci. 2022 Nov 16;9(11):636. doi: 10.3390/vetsci9110636. Vet Sci. 2022. PMID: 36423085 Free PMC article.
54 results